A feasibility study of sequential doublet chemotherapy comprising carboplatin–doxorubicin and carboplatin–paclitaxel for advanced endometrial adenocarcinoma and carcinosarcoma-Reference-Cited by-同舟云学术

A feasibility study of sequential doublet chemotherapy comprising carboplatin–doxorubicin and carboplatin–paclitaxel for advanced endometrial adenocarcinoma and carcinosarcoma

Published:2009-11 Issue:11 Volume:20 Page:1787-1793
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Ang J.E.,Shah R.N.,Everard M.,Keyzor C.,Coombes I.,Jenkins A.,Thomas K.,A'Hern R.,Jones R.L.,Blake P.,Gabra H.,Hall G.,Gore M.E.,Kaye S.B.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/20/11/1787/472059/mdp193.pdf

Reference26 articles.

1. Cancer statistics, 2006;Jemal;CA Cancer J Clin,2006

2. Hormonal therapy of endometrial cancer;Markman;Eur J Cancer,2005

3. Phase II study of carboplatin in patients with advanced or recurrent endometrial carcinoma. A trial of the EORTC Gynaecological Cancer Group;Van Wijk;Eur J Cancer,2003

4. Systemic treatment of advanced and recurrent endometrial carcinoma: current status and future directions;Moore;J Clin Oncol,1991

5. Topotecan is an active agent in the first-line treatment of metastatic or recurrent endometrial carcinoma: Eastern Cooperative Oncology Group Study E3E93;Wadler;J Clin Oncol,2003

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of checkpoint kinase prevents human oocyte apoptosis induced by chemotherapy and allows enhanced tumour chemotherapeutic efficacy;Human Reproduction;2023-07-14

2. British Gynaecological Cancer Society (BGCS) uterine cancer guidelines: Recommendations for practice;European Journal of Obstetrics & Gynecology and Reproductive Biology;2022-03

3. BGCS uterine cancer guidelines: Recommendations for practice;European Journal of Obstetrics & Gynecology and Reproductive Biology;2017-06

4. Paclitaxel and Carboplatin in Patients With Completely or Optimally Resected Carcinosarcoma of the Uterus: A Phase II Trial by the Japanese Uterine Sarcoma Group and the Tohoku Gynecologic Cancer Unit;International Journal of Gynecologic Cancer;2015-01

5. Risk assessment of radio-chemotherapy in pediatric soft tissue sarcomas;Journal of Radiation Research and Applied Sciences;2015-01